These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 15646679)

  • 1. [Acute giant cell hepatitis in a 17-year old man].
    Muñoz P; Drobinska A; Bianchi L; Züger Ch; Pirovino M
    Praxis (Bern 1994); 2004 Dec; 93(50):2109-12. PubMed ID: 15646679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Painless jaundice after ecstasy and alcohol consumption].
    Kis L; Pfaffenberger M
    Praxis (Bern 1994); 2007 Jun; 96(25-26):1035-7. PubMed ID: 17639967
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute liver failure following the use of ecstasy (MDMA)].
    Lange-Brock N; Berg T; Müller AR; Fliege H; Neuhaus P; Wiedenmann B; Klapp BF; Mönnikes H
    Z Gastroenterol; 2002 Aug; 40(8):581-6. PubMed ID: 12297982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Acute liver damage after using ecstasy].
    Shiloach E; Zecler E; Horowiz M; Scapa E
    Harefuah; 1998 Feb; 134(4):266-9, 335. PubMed ID: 10909502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hepatitis and Ecstasy].
    Pascual Bartolomé S; Sarrión Martínez JV; García Herola A; Berenguer Lapuerta J
    Med Clin (Barc); 1997 Feb; 108(7):279. PubMed ID: 9121201
    [No Abstract]   [Full Text] [Related]  

  • 6. 3,4-methylenedioxymethamphetamine (MDMA): an important cause of acute hepatitis.
    Brncić N; Kraus I; Visković I; Mijandrusić-Sincić B; Vlahović-Palcevski V
    Med Sci Monit; 2006 Nov; 12(11):CS107-9. PubMed ID: 17072276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 6-2001. A 17-year-old girl with marked jaundice and weight loss.
    N Engl J Med; 2001 Feb; 344(8):591-9. PubMed ID: 11207356
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hepatitis from ecstasy].
    Giner Durán R; Flors H; Millán M; Manzanera R
    Gastroenterol Hepatol; 1998 Mar; 21(3):158. PubMed ID: 9607299
    [No Abstract]   [Full Text] [Related]  

  • 9. Ecstasy induced acute hepatic failure. Case reports.
    Atayan Y; Çağın YF; Erdoğan MA; Harputluoglu MM; Bilgic Y
    Acta Gastroenterol Belg; 2015; 78(1):53-5. PubMed ID: 26118578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe chronic hepatitis secondary to prolonged use of ecstasy and cocaine.
    Payancé A; Scotto B; Perarnau JM; de Muret A; Bacq Y
    Clin Res Hepatol Gastroenterol; 2013 Nov; 37(5):e109-13. PubMed ID: 23910059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute hepatitis due to ecstasy].
    Roques V; Perney P; Beaufort P; Hanslik B; Ramos J; Durand L; Le Bricquir Y; Blanc F
    Presse Med; 1998 Mar; 27(10):468-70. PubMed ID: 9767974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-Methylenedioxymethamphetamine (ecstasy)-induced hepatotoxicity: multidetector CT and pathology findings.
    Lawler LP; Abraham S; Fishman EK
    J Comput Assist Tomogr; 2001; 25(4):649-52. PubMed ID: 11473199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hair analysis in the diagnosis of toxic hepatitis after Ecstasy abuse].
    Skopp G; Aderjan R; Koster J
    Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1165-8. PubMed ID: 7656850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatic and hematological complications following ecstasy usage].
    Shibolet O; Kalish Y; Gillis S; Ilan Y
    Harefuah; 2001 Oct; 140(10):911-4, 991. PubMed ID: 11681122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Toxicity of ecstasy].
    Lapostolle F; Eliez CA; el Massioui Y; Adnet F; Leclerc G; Efthymiou ML; Baud F
    Presse Med; 1997 Dec; 26(38):1881-4. PubMed ID: 9569916
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic ecstasy (3,4-methylenedioxymetamphetamine) abuse: a recurrent and unpredictable cause of severe acute hepatitis.
    Fidler H; Dhillon A; Gertner D; Burroughs A
    J Hepatol; 1996 Oct; 25(4):563-6. PubMed ID: 8912157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecstasy induced fatal hepatic failure.
    Colak Y; Tuncer I; Enc FY; Ozturk O; Kiziltas S; Ulasoglu C
    J Gastrointestin Liver Dis; 2011 Jun; 20(2):215-6. PubMed ID: 21725523
    [No Abstract]   [Full Text] [Related]  

  • 18. [Acute hepatitis induced by Ecstasy].
    Indart Pérez A; Mendia Gorostidi A; Barrio Andrés J; Arens Miravé I
    Gastroenterol Hepatol; 1998 Dec; 21(10):499. PubMed ID: 9927798
    [No Abstract]   [Full Text] [Related]  

  • 19. Ecstasy (MDMA) and high prevalence psychiatric symptomatology: somatic anxiety symptoms are associated with polydrug, not ecstasy, use.
    Bedi G; Van Dam NT; Redman J
    J Psychopharmacol; 2010 Feb; 24(2):233-40. PubMed ID: 18832429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Morphological aspects of liver damage in drug addiction and abuse].
    Heilmann K; Linhart P; Weizel A
    Dtsch Med Wochenschr; 1971 Mar; 96(11):453-7. PubMed ID: 5548184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.